Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the therapeutic effects of saffron in type 2 diabetes
IRCT20100127003217N13Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of saffron in type 2 diabetes mellitus (T2DM), sponsored by Tabriz University of Medical Sciences. Started Dec 2020; status: completed.
02
Drugs
saffron
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20100127003217N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100127003217N13.